首頁 > 市場調查報告書 > 醫療設備

導管消化器

胃腸道支架市場規模、佔有率和成長分析（按產品、材質、應用、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1898578

胃腸道支架市場規模、佔有率和成長分析（按產品、材質、應用、最終用戶和地區分類）—2026-2033年產業預測

Gastrointestinal Stents Market Size, Share, and Growth Analysis, By Products (Biliary Stents, Duodenal Stents), By Material (Self-Expanding Metal Stents, Nitinol), By Application, By End Users, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，胃腸道支架市場規模將達到 52.9 億美元，到 2025 年將達到 55.8 億美元，到 2033 年將達到 85.6 億美元，在預測期（2026-2033 年）內，複合年成長率為 5.5%。

受胃腸道疾病發病率上升和人口老化的推動，胃腸道支架市場持續穩定成長。生活方式的改變、不健康的飲食習慣以及肥胖率的上升等因素導致結腸癌和發炎性腸道疾病病例的增加。胃腸道疾病的激增推動了對支架的需求，支架是治療方法改善患者的生活品質。隨著人口老化，與老齡化相關的胃腸道疾病，例如狹窄和憩室炎，也變得越來越常見，進一步刺激了市場需求。自膨式金屬支架和可生物分解支架等創新技術正在改變治療效果，而具有防移位功能的新型設計則正在提高支架的長期療效和患者舒適度。

胃腸道支架市場促進因素

患者和醫療專業人員對胃腸道支架益處的認知不斷提高，有助於胃腸道疾病的早期發現和及時治療。此外，新興地區醫療服務可近性的改善也促使支架置入術的使用量激增。這種認知的提高，加上醫療基礎設施的改善，使得更多患者尋求有效緩解症狀的方法，從而推動了對這些創新醫療設備的需求，並顯著促進了胃腸道支架市場的擴張。教育和醫療服務的可近性相結合，在該領域治療方法的變革中發揮關鍵作用。

胃腸道支架市場的限制因素

在某些地區，與胃腸道支架手術相關的報銷政策可能較為嚴格，並附加諸多限制條件。這些限制可能會對支架治療方案的成本效益和可近性產生不利影響。因此，面臨經濟困難的患者可能不願意接受此類醫療干預，最終可能阻礙市場擴張。報銷不足或手術複雜可能會降低醫療服務提供者推薦或使用這些器械的意願，導致整體需求下降。因此，這些限制對醫療服務提供者和患者均有影響，並可能對胃腸道支架市場的成長和發展構成重大挑戰。

胃腸道支架市場趨勢

胃腸道支架市場正顯著轉向可生物分解支架，這反映出醫療服務提供者和患者越來越傾向於選擇能夠改善治療效果的創新解決方案。與傳統的金屬支架相比，可生物分解支架具有顯著優勢，主要體現在無需繁瑣的取出手術，同時最大限度地減少了與永久植入相關的併發症。這些支架的設計使其能夠逐漸溶解，在癒合過程中為患處提供有效支撐，並促進組織自然再生。這一趨勢凸顯了胃腸道治療領域以患者為中心的醫療設備發展趨勢，即優先考慮安全性、便利性和整體照護品質的提升。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Boston Scientific Corporation（USA）
BD（Becton, Dickinson and Company）（USA）
Cook Medical（USA）
Olympus Corporation（Japan）
Merit Medical Systems（USA）
CONMED Corporation（USA）
ELLA-CS sro（Czech Republic）
Hobbs Medical Inc.（USA）
Taewoong Medical Co. Ltd.（South Korea）
S&G Biotech Inc.（South Korea）
Medtronic（Ireland）
AbbVie（USA）
Johnson & Johnson（USA）
Takeda Pharmaceutical Company Limited（Japan）
Pfizer Inc.（USA）
Novartis AG（Switzerland）
Bayer AG（Germany）
AstraZeneca plc（UK）
Roche Holding AG（Switzerland）
Eli Lilly and Company（USA）

結論與建議

簡介目錄

Product Code: SQMIG35A2398

Gastrointestinal Stents Market size was valued at USD 5.29 Billion in 2024 and is poised to grow from USD 5.58 Billion in 2025 to USD 8.56 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The gastrointestinal stents market is witnessing consistent growth, fueled by the rising incidence of gastrointestinal disorders and an expanding elderly population. Factors such as lifestyle changes, unhealthy diets, and increasing obesity rates have led to more cases of conditions like colorectal cancer and inflammatory bowel disease. This surge in gastrointestinal issues has increased the demand for stents, known for their effective and minimally invasive treatments that enhance patients' quality of life. As the elderly population grows, age-related gastrointestinal ailments such as strictures and diverticulitis are becoming more common, further driving demand. Innovations like self-expandable metal stents and biodegradable options are transforming treatment outcomes, while new designs with anti-migration features enhance long-term effectiveness and patient comfort in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Gastrointestinal Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Gastrointestinal Stents Market Segments Analysis

Global Gastrointestinal Stents Market is segmented by products, material, application, end users and region. Based on products, the market is segmented into biliary stents, duodenal stents, colonic stents, pancreatic stents and esophageal stents. Based on material, the market is segmented into self-expanding metal stents, nitinol, plastic stents and others. Based on application, the market is segmented into biliary diseases, irritable bowel syndrome, gastrointestinal cancers, colorectal cancer, stomach cancer, esophageal cancer and pancreatic cancer. Based on end users, the market is segmented into hospitals and clinics and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Gastrointestinal Stents Market

The increasing awareness of the advantages of gastrointestinal stents among both patients and healthcare professionals has contributed to early detection and prompt treatment of gastrointestinal issues. Additionally, enhanced accessibility to healthcare services in emerging regions has led to a surge in the utilization of stenting procedures. This growing recognition, coupled with improved healthcare infrastructure, has significantly fueled the expansion of the gastrointestinal stents market, as more individuals seek effective solutions for their conditions, thereby driving demand for these innovative medical devices. The combination of education and access is playing a crucial role in transforming treatment approaches in this field.

Restraints in the Gastrointestinal Stents Market

Certain areas experience restrictions in reimbursement policies related to gastrointestinal stent procedures, which may impose rigorous requirements. This limitation can adversely affect the affordability and accessibility of stent-based treatment options. As a result, patients facing financial constraints may be deterred from seeking these medical interventions, ultimately stymying market expansion. When reimbursement is inadequate or difficult to navigate, healthcare providers might hesitate to recommend or utilize these devices, leading to a decrease in overall demand. Consequently, these constraints can present significant challenges for the growth and development of the gastrointestinal stents market, affecting both providers and patients alike.

Market Trends of the Gastrointestinal Stents Market

The gastrointestinal stents market is witnessing a notable shift towards biodegradable options, reflecting a growing preference among healthcare providers and patients for innovative solutions that enhance treatment outcomes. Biodegradable stents present clear benefits over traditional metallic alternatives, primarily by eliminating the need for cumbersome removal procedures while simultaneously minimizing complications related to permanent implants. As these stents are designed to dissolve gradually, they support affected areas effectively during the healing process, allowing for natural tissue regeneration. This trend underscores a broader movement towards patient-centric medical devices that prioritize safety, convenience, and improved overall care in gastrointestinal treatments.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Gastrointestinal Stents Market Size by Products & CAGR (2026-2033)

Market Overview
Biliary Stents
Duodenal Stents
Colonic Stents
Pancreatic Stents
Esophageal Stents

Global Gastrointestinal Stents Market Size by Material & CAGR (2026-2033)

Market Overview
Self-Expanding Metal Stents
Nitinol
Plastic Stents
Others

Global Gastrointestinal Stents Market Size by Application & CAGR (2026-2033)

Market Overview
Biliary Diseases
Irritable Bowel Syndrome
Gastrointestinal Cancers
Colorectal Cancer
Stomach Cancer
Esophageal Cancer
Pancreatic Cancer

Global Gastrointestinal Stents Market Size by End Users & CAGR (2026-2033)

Market Overview
Hospitals And Clinics
Ambulatory Surgical Centers

Global Gastrointestinal Stents Market Size & CAGR (2026-2033)

North America (Products, Material, Application, End Users)
- USA
- Canada
Europe (Products, Material, Application, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Products, Material, Application, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Products, Material, Application, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Products, Material, Application, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CONMED Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ELLA-CS s.r.o. (Czech Republic)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hobbs Medical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taewoong Medical Co. Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
S&G Biotech Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments